Why the study?
Do new antihypertensive agents improve quality of life and compliance compared to traditional therapy in patients with mild hypertension?
Do new antihypertensive agents improve quality of life and compliance compared to traditional therapy in patients with mild hypertension?
Quality of life and side effect profiles are important considerations when selecting antihypertensive therapy for mild hypertension to improve patient compliance.
Answers are grounded in this paper and cite their sources.
Clinicians should factor quality-of-life effects into mild-hypertension prescribing; leaves open which agents best optimize compliance.
Treatment of mild hypertension is becoming increasingly accepted, and many more patients are receiving antihypertensive drugs. A number of new agents offer potential benefits over traditional therapy. These benefits are due to differences in side effect profiles, which have the potential for improved compliance. Quality of life is an important consideration in the selection of antihypertensive therapy.
No takes yet. Share an insight, caveat, or question.
R E Rakel (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: